Indication
Herpes simplex infection
Herpes simplex infection is a prevalent, lifelong viral condition caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2). Read more about Herpes simplex infection
46 drugs 44 manufacturers
Drugs that treat it
Common Herpes simplex infection therapies.
ACYCLOVIR
ACYCLOVIR
ACYCLOVIR
ACYCLOVIR
ACYCLOVIR
ACYCLOVIR
ACYCLOVIR SODIUM
ACYCLOVIR
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHerpes simplex infection is a prevalent, lifelong viral condition caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2).
The pathogen primarily affects the mucocutaneous membranes and the nervous system, typically manifesting as oral or genital lesions, but it can also cause ocular, cutaneous, or central nervous system disease, with increased risk for severe complications in neonates and immunocompromised individuals.
Pathophysiologically, the virus replicates locally in epithelial cells—producing characteristic clusters of painful, fluid-filled vesicles that ulcerate and crust—before migrating via sensory neurons to establish lifelong latency in sensory ganglia.
Clinical reactivations occur intermittently when the latent virus travels back to the epithelial surface, resulting in either symptomatic recurrent outbreaks or asymptomatic viral shedding.
- cdc.gov
Herpes simplex infection is a prevalent, lifelong viral condition caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) Clinical reactivations occur intermittently when the latent virus travels back to the epithelial surface, resulting in either symptomatic recurrent outbreaks or asymptomatic viral shedding
- hiv.gov
Herpes simplex infection is a prevalent, lifelong viral condition caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) The pathogen primarily affects the mucocutaneous membranes and the nervous system, typically manifesting as oral or genital lesions, but it can also cause ocular, cutaneous, or central nervous system disease, with increased risk for severe complications in neonates and immunocompromised individuals Pathophysiologically, the virus replicates locally in epithelial cells...
- medlineplus.gov
The pathogen primarily affects the mucocutaneous membranes and the nervous system, typically manifesting as oral or genital lesions, but it can also cause ocular, cutaneous, or central nervous system disease, with increased risk for severe complications in neonates and immunocompromised individuals Pathophysiologically, the virus replicates locally in epithelial cells—producing characteristic clusters of painful, fluid-filled vesicles that ulcerate and crust—before migrating via sensory neurons ...
- nih.gov
Clinical reactivations occur intermittently when the latent virus travels back to the epithelial surface, resulting in either symptomatic recurrent outbreaks or asymptomatic viral shedding
Personalize your experience
Follow Herpes simplex infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.